Yc Avl Communicatie 1309

TIL team wins Patient Impact Award 2023


The TIL treatment team wins this year’s Patient Impact Award, The Netherlands Cancer Institute’s annual award for the most impactful clinical innovation. For decades, it seemed like nothing but a dream: making a drug from cancer patients' own immune cells. And yet: our TIL team developed a cell therapy that does just that. Today, medical oncologist and principal investigator John Haanen accepted the prize.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.